Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2007 2
2008 1
2009 2
2010 3
2011 4
2012 2
2013 7
2014 2
2015 3
2016 3
2017 7
2018 7
2019 18
2020 9
2021 10
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
IMPACT OF MESALAZINE ON THE RESPONSE TO COVID-19 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. RESULTS OF A PROSPECTIVE MULTICENTRE STUDY OF GETECCU (VACOVEII STUDY).
Deza DC, Julián Gomara AB, Biota EC, Beltrán B, Domènech E, Casbas AG, Mañosa M, Zabana Y, Alfaro LR, Romero EV, González EG, Sicilia B, Laredo V, Alcalá Escriche MJ, Velázquez LM, Iglesias RF, Pérez AP, Calafat M, Iturria SR, Yudego IM, Nieto YB, Mateo SG, Gisbert JP, Lidón RV, Arias L, Alfambra E, Roche PC, de Acosta MB, López SG. Deza DC, et al. Among authors: beltran b. Gastroenterol Hepatol. 2024 Jan 12:S0210-5705(24)00017-7. doi: 10.1016/j.gastrohep.2023.12.012. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38219960 English, Spanish.
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, P Gisbert J, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Among authors: beltran b. Gastroenterol Hepatol. 2023 Nov 23:S0210-5705(23)00474-0. doi: 10.1016/j.gastrohep.2023.11.004. Online ahead of print. Gastroenterol Hepatol. 2023. PMID: 38007154 English, Spanish.
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's Disease.
Iborra M, Moret I, Busó E, García-Giménez JL, Ricart E, Gisbert JP, Cabré E, Esteve M, Márquez-Mosquera L, García-Planella E, Guardiola J, Pallardó FV, Serena C, Algaba-Chueca F, Domenech E, Nos P, Beltrán B. Iborra M, et al. Among authors: beltran b. Int J Mol Sci. 2022 Dec 14;23(24):15881. doi: 10.3390/ijms232415881. Int J Mol Sci. 2022. PMID: 36555526 Free PMC article.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
The characteristics of the stricture, but not the ongoing treatment, could influence the outcome of endoscopic dilation in recurrent Crohn's disease.
Ladrón Abia P, Alonso N, Mínguez Sabater A, Gimeno Torres M, Bastida G, Aguas M, Beltrán B, Sáez-González E, Pons V, Nos P, Iborra M. Ladrón Abia P, et al. Among authors: beltran b. Gastroenterol Hepatol. 2022 Oct;45(8):614-620. doi: 10.1016/j.gastrohep.2022.01.004. Epub 2022 Jan 19. Gastroenterol Hepatol. 2022. PMID: 35065172 English, Spanish.
Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study).
Sainz E, Zabana Y, Miguel I, Fernández-Clotet A, Beltrán B, Núñez L, García MJ, Martín-Arranz MD, Iglesias E, Cañete F, Gutiérrez A, Piqueras M, Pérez-Martínez I, Bujanda L, Rodríguez-Lago I, Casanova MJ, Navarro P, Vicente R, Merino O, Algaba A, Rodríguez C, Huguet JM, Fernández-Bañares F, Domènech E, Esteve M; ENEIDA registry of GETECCU. Sainz E, et al. Among authors: beltran b. Aliment Pharmacol Ther. 2021 Oct;54(8):1041-1051. doi: 10.1111/apt.16547. Epub 2021 Aug 18. Aliment Pharmacol Ther. 2021. PMID: 34406676
Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience.
Barreiro-de Acosta M, Gutiérrez A, Zabana Y, Beltrán B, Calvet X, Chaparro M, Domènech E, Esteve M, Panés J, Gisbert JP, Nos P; on behalf GETECCU. Barreiro-de Acosta M, et al. Among authors: beltran b. United European Gastroenterol J. 2021 Sep;9(7):766-772. doi: 10.1002/ueg2.12105. Epub 2021 Jun 5. United European Gastroenterol J. 2021. PMID: 34089303 Free PMC article.
75 results